원발성 삼출액 림프종 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "원발성 삼출액 림프종" in Korean language version.

refsWebsite

Global rank Korean rank

9doi.org

2^nd place

3^rd place

9nih.gov

4^th place

8semanticscholar.org

11^th place

310^th place

doi.org

dx.doi.org

Chen BJ, Chuang SS (March 2020). “Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches”. 《Advances in Anatomic Pathology》 27 (2): 61–74. doi:10.1097/PAP.0000000000000253. PMID 31725418. S2CID 208039484.
Korkolopoulou P, Vassilakopoulos T, Milionis V, Ioannou M (July 2016). “Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review”. 《Advances in Anatomic Pathology》 23 (4): 202–43. doi:10.1097/PAP.0000000000000117. PMID 27271843. S2CID 205915174.
Rezk SA, Zhao X, Weiss LM (September 2018). “Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update”. 《Human Pathology》 79: 18–41. doi:10.1016/j.humpath.2018.05.020. PMID 29885408. S2CID 47010934.
Shimada K, Hayakawa F, Kiyoi H (November 2018). “Biology and management of primary effusion lymphoma”. 《Blood》 132 (18): 1879–1888. doi:10.1182/blood-2018-03-791426. PMID 30154110. S2CID 206957482.
El-Fattah MA (December 2017). “Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients”. 《Hematological Oncology》 35 (4): 878–883. doi:10.1002/hon.2372. PMID 27859456. S2CID 21614181.
Zanelli M, Zizzo M, Bisagni A, Froio E, De Marco L, Valli R, Filosa A, Luminari S, Martino G, Massaro F, Fratoni S, Ascani S (April 2020). “Germinotropic lymphoproliferative disorder: a systematic review”. 《Annals of Hematology》 99 (10): 2243–2253. doi:10.1007/s00277-020-04024-3. PMID 32307569. S2CID 215819914.
Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ (January 2020). “Diffuse large B-cell lymphoma variants: an update”. 《Pathology》 52 (1): 53–67. doi:10.1016/j.pathol.2019.08.013. PMID 31735345. S2CID 208142227.
Gonçalves PH, Uldrick TS, Yarchoan R (September 2017). “HIV-associated Kaposi sarcoma and related diseases”. 《AIDS》 31 (14): 1903–1916. doi:10.1097/QAD.0000000000001567. PMC 6310482. PMID 28609402.
Arora N, Gupta A, Sadeghi N (July 2017). “Primary effusion lymphoma: current concepts and management”. 《Current Opinion in Pulmonary Medicine》 23 (4): 365–370. doi:10.1097/MCP.0000000000000384. PMID 28399009. S2CID 4514140.

nih.gov

ncbi.nlm.nih.gov

Chen BJ, Chuang SS (March 2020). “Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches”. 《Advances in Anatomic Pathology》 27 (2): 61–74. doi:10.1097/PAP.0000000000000253. PMID 31725418. S2CID 208039484.
Korkolopoulou P, Vassilakopoulos T, Milionis V, Ioannou M (July 2016). “Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review”. 《Advances in Anatomic Pathology》 23 (4): 202–43. doi:10.1097/PAP.0000000000000117. PMID 27271843. S2CID 205915174.
Rezk SA, Zhao X, Weiss LM (September 2018). “Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update”. 《Human Pathology》 79: 18–41. doi:10.1016/j.humpath.2018.05.020. PMID 29885408. S2CID 47010934.
Shimada K, Hayakawa F, Kiyoi H (November 2018). “Biology and management of primary effusion lymphoma”. 《Blood》 132 (18): 1879–1888. doi:10.1182/blood-2018-03-791426. PMID 30154110. S2CID 206957482.
El-Fattah MA (December 2017). “Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients”. 《Hematological Oncology》 35 (4): 878–883. doi:10.1002/hon.2372. PMID 27859456. S2CID 21614181.
Zanelli M, Zizzo M, Bisagni A, Froio E, De Marco L, Valli R, Filosa A, Luminari S, Martino G, Massaro F, Fratoni S, Ascani S (April 2020). “Germinotropic lymphoproliferative disorder: a systematic review”. 《Annals of Hematology》 99 (10): 2243–2253. doi:10.1007/s00277-020-04024-3. PMID 32307569. S2CID 215819914.
Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ (January 2020). “Diffuse large B-cell lymphoma variants: an update”. 《Pathology》 52 (1): 53–67. doi:10.1016/j.pathol.2019.08.013. PMID 31735345. S2CID 208142227.
Gonçalves PH, Uldrick TS, Yarchoan R (September 2017). “HIV-associated Kaposi sarcoma and related diseases”. 《AIDS》 31 (14): 1903–1916. doi:10.1097/QAD.0000000000001567. PMC 6310482. PMID 28609402.
Arora N, Gupta A, Sadeghi N (July 2017). “Primary effusion lymphoma: current concepts and management”. 《Current Opinion in Pulmonary Medicine》 23 (4): 365–370. doi:10.1097/MCP.0000000000000384. PMID 28399009. S2CID 4514140.

semanticscholar.org

api.semanticscholar.org

Chen BJ, Chuang SS (March 2020). “Lymphoid Neoplasms With Plasmablastic Differentiation: A Comprehensive Review and Diagnostic Approaches”. 《Advances in Anatomic Pathology》 27 (2): 61–74. doi:10.1097/PAP.0000000000000253. PMID 31725418. S2CID 208039484.
Korkolopoulou P, Vassilakopoulos T, Milionis V, Ioannou M (July 2016). “Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review”. 《Advances in Anatomic Pathology》 23 (4): 202–43. doi:10.1097/PAP.0000000000000117. PMID 27271843. S2CID 205915174.
Rezk SA, Zhao X, Weiss LM (September 2018). “Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update”. 《Human Pathology》 79: 18–41. doi:10.1016/j.humpath.2018.05.020. PMID 29885408. S2CID 47010934.
Shimada K, Hayakawa F, Kiyoi H (November 2018). “Biology and management of primary effusion lymphoma”. 《Blood》 132 (18): 1879–1888. doi:10.1182/blood-2018-03-791426. PMID 30154110. S2CID 206957482.
El-Fattah MA (December 2017). “Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients”. 《Hematological Oncology》 35 (4): 878–883. doi:10.1002/hon.2372. PMID 27859456. S2CID 21614181.
Zanelli M, Zizzo M, Bisagni A, Froio E, De Marco L, Valli R, Filosa A, Luminari S, Martino G, Massaro F, Fratoni S, Ascani S (April 2020). “Germinotropic lymphoproliferative disorder: a systematic review”. 《Annals of Hematology》 99 (10): 2243–2253. doi:10.1007/s00277-020-04024-3. PMID 32307569. S2CID 215819914.
Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ (January 2020). “Diffuse large B-cell lymphoma variants: an update”. 《Pathology》 52 (1): 53–67. doi:10.1016/j.pathol.2019.08.013. PMID 31735345. S2CID 208142227.
Arora N, Gupta A, Sadeghi N (July 2017). “Primary effusion lymphoma: current concepts and management”. 《Current Opinion in Pulmonary Medicine》 23 (4): 365–370. doi:10.1097/MCP.0000000000000384. PMID 28399009. S2CID 4514140.